Myotubularin-related Protein 9 (MTMR9) in Muscle Fibers and Myofibers

Target Name: MTMR9LP

NCBI ID: G339483

MTMR9LP

Other Name(s): Myotubularin related protein 9 like, pseudogene | FLJ30998 | MTMR9L | myotubularin related protein 9 like, pseudogene

Myotubularin-related Protein 9 (MTMR9) in Muscle Fibers and Myofibers

Myotubularin related protein 9 (MTMR9) is a protein that is expressed in human muscle tissue, including muscle fibers and myofibers. It is a member of the myotubularin gene family, which is known for the structure and function of the myotubularin protein. The myotubularin gene has four exons, which encode a protein that is composed of multiple domains, including a transmembrane region, a cytoplasmic domain, and an N-terminus.

MTMR9 is a 21-kDa protein that is expressed in human muscle tissue, including muscle fibers and myofibers. It is characterized by a molecular weight of 42 kDa and a calculated pI of 6.3. MTMR9 is predominantly expressed in muscle fibers, with lower levels of expression in muscle cells and other tissues. It is also expressed in the heart, liver, and pancreas, and has been shown to be involved in a variety of cellular processes, including muscle growth, differentiation, and regeneration.

MTMR9 has been shown to play a role in several cellular processes, including cell signaling, protein synthesis, and cellular mechanics. It is a component of the myosin ATPase, which is a protein that is involved in the process of muscle contraction. MTMR9 is also shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and regeneration.

In addition to its role in cellular signaling, MTMR9 has also been shown to be involved in the regulation of protein synthesis. It is a known regulator of the myotubulin protein, which is a key component of muscle fibers. MTMR9 has been shown to interact with myotubulin and regulate its stability, which in turn affects the level of myotubulin available for cross-bridge formation and the rate of muscle contraction.

MTMR9 has also been shown to be involved in the regulation of cellular mechanics. It is a known regulator of the cytoskeleton, which is the structure that gives cells their shape and supports their mechanical forces. MTMR9 is involved in the regulation of actin dynamics, which is the movement of actin filaments along the cytoskeleton. This is important for things like cell division, migration, and mechanical force transmission.

Despite its involvement in several cellular processes, MTMR9 is not well understood, and there is limited research on its function in human disease. However, studies in animal models have shown that MTMR9 is involved in several processes that are relevant to human disease, including muscle growth, differentiation, and regeneration.

In addition to its potential role in drug development, MTMR9 may also be a useful biomarker for certain diseases. For example, MTMR9 has been shown to be decreased in muscle fibers after exercise, which could be a useful biomarker for muscle damage or disease. Additionally, MTMR9 has been shown to be decreased in the hearts of individuals with certain genetic disorders, such as muscular dystrophy, which could be a useful biomarker for these conditions.

Conclusion
In conclusion, MTMR9 is a protein that is expressed in human muscle tissue and is involved in several cellular processes, including cell signaling, protein synthesis, and cellular mechanics. It has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. MTMR9 may also be a useful biomarker for certain diseases, and further research is needed to fully understand its function in human disease.

Protein Name: Myotubularin Related Protein 9 Like, Pseudogene

The "MTMR9LP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTMR9LP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets